Weaver C. Barksdale & Associates’s Convergys CVG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$16K Buy
667
+46
+7% +$1.14K 0.02% 199
2017
Q3
$16K Sell
621
-8
-1% -$192 0.02% 191
2017
Q2
$15K Sell
629
-83
-12% -$1.93K 0.02% 198
2017
Q1
$15K Buy
712
+53
+8% +$1.25K 0.02% 201
2016
Q4
$16K Buy
659
+180
+38% +$4.84K 0.03% 193
2016
Q3
$15K Buy
479
+5
+1% +$142 0.03% 188
2016
Q2
$12K Buy
474
+25
+6% +$674 0.02% 202
2016
Q1
$12K Sell
449
-27
-6% -$676 0.01% 239
2015
Q4
$12K Sell
476
-76
-14% -$1.92K 0.01% 229
2015
Q3
$13K Buy
552
+16
+3% +$381 0.01% 212
2015
Q2
$14K Sell
536
-32
-6% -$775 0.01% 213
2015
Q1
$13K Buy
568
+25
+5% +$529 0.01% 232
2014
Q4
$11K Sell
543
-29
-5% -$576 0.01% 255
2014
Q3
$10K Buy
572
+130
+29% +$2.53K 0.01% 272
2014
Q2
$9K Buy
442
+28
+7% +$608 0.01% 296
2014
Q1
$9K Buy
414
+12
+3% +$249 0.01% 291
2013
Q4
$8K Sell
402
-25
-6% -$498 0.01% 320
2013
Q3
$8K Sell
427
-23
-5% -$431 0.01% 322
2013
Q2
$8K Buy
+450
New +$7.82K 0.01% 315

Other funds holding CVG

Weaver C. Barksdale & Associates's CVG Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Convergys (CVG) stake by 7.4% in Q4 2017, buying an estimated $1.14K and bringing the position to 667 shares worth $16K. The position accounts for 0.02% of the portfolio, ranked #199.

Weaver C. Barksdale & Associates first reported a position in CVG in Q2 2013 and has held it in 19 quarters since. 269 funds tracked by Wall St. Rank hold CVG as of Q4 2017.

  • Weaver C. Barksdale & Associates held 667 shares of Convergys worth $16K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 46 Convergys shares in Q4 2017, an estimated $1.14K.
  • Convergys made up 0.02% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #199 holding.
  • Weaver C. Barksdale & Associates first reported a position in Convergys in Q2 2013 and has held it in 19 quarters since.
  • 269 funds tracked by Wall St. Rank held Convergys as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.